Posts

5 Next-Generation Psychedelics Entering Clinical Trials This YearShutterstock

5 Next-Generation Psychedelics Entering Clinical Trials This Year

,
Modernized psychedelic medicine is coming, whether you like it or not, so here are five of the most exciting next-generation psychedelics on the horizon.

Psychedelic Business Spotlight – May 13

,
This week in psychedelic business news: Beckley Retreats set launch; another shark swims into the psychedelics industry; and MindMed shares promising LSD study results.
Shutterstock

Why Field Trip Health Is Dividing in Two — and What This Means for Investors

,
Field Trip Health plans to split into two independent, publicly traded companies: Field Trip Health and Wellness and Reunion Neuroscience.
Psychedelic Business Spotlight - April 29

Psychedelic Business Spotlight – April 29

,
This week in psychedelic business news: Field Trip Health splits in two, Tryp Therapeutics commences study, and Optimi Health celebrates new facility.
Psychedelic Business Spotlight - April 8

Psychedelic Business Spotlight – April 8

,
This week in psychedelic business news: Field Trip Health secures a patent; Core One Labs seeks more retail investors; a new CEO takes over GABA Therapeutics.
My Favorite Psychedelic Stocks Part 1Shutterstock

My Favorite Psychedelic Stocks: Part 1

,
Our resident Psychedelic Investor details five companies he thinks are in strong position to win the psychedelic medicine race.
Psychedelic Business Spotlight - March 4

Psychedelic Business Spotlight – March 4

,
This week in psychedelic business news: Field Trip partners with Cerebral; Benzinga forms Psychedelic Advisory Council; Incannex pursues virtual reality psychedelic therapy.

Psychedelic Business Spotlight – February 25

,
This week in psychedelic business news: Core One cheapens psilocybin production; Field Trip eyes Oregon; Small Pharma advances DMT.
Psychedelic Business Spotlight — January 14

Psychedelic Business Spotlight — January 14

,
This week in psychedelic business news: Another psychedelics company starts trading on OTCQB; another ketamine trial delivers; and another patent is issued.
Is ‘The Trip’ Essential to The Psychedelic Experience?

Is ‘The Trip’ Essential to The Psychedelic Experience?

Biology and experience are tough to separate, but some researchers are exploring the possibility of non-hallucinogenic psychedelics as a mental health treatment. This begs the question: what do we...